CarlJackFichtenbaumMD

Infectious Disease • Cincinnati, OH

HIV/AIDS Medicine

Professor of Medicine, University Cincinnati

Join to view full profile

Dr. Fichtenbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fichtenbaum's full profile

Already have an account?

Office
200 Albert Sabin Way
Cincinnati, OH 45267
Phone+1 513-584-6977

Fax+1 513-584-6386
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 1991 - 1994
Yale-New Haven Medical CenterFellowship, Infectious Disease, 1990 - 1991
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 1985 - 1990
University of Missouri Kansas City School of MedicineClass of 1985

Certifications & Licensure

OH State Medical License 1999 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
Completed
Phase 2
DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) Start of enrollment: 2006 May 01
Terminated
Phase 3
HIV Screening in the Emergency Department Setting Start of enrollment: 2008 Jan 01
Completed
Not Applicable
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study Start of enrollment: 2009 Jan 01
Completed
Phase 1, Phase 2
Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection Start of enrollment: 2005 Oct 01
Completed
Phase 4
Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery Start of enrollment: 2014 Jul 02
Completed
Phase 2
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Start of enrollment: 2014 May 30
Completed
Phase 1
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure Start of enrollment: 2014 Dec 01
Completed
Phase 3
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) Start of enrollment: 2015 Dec 21
Completed
Phase 1, Phase 2
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV Start of enrollment: 2023 May 30
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIV.
Maheen Z Abidi, Triin Umbleja, Edgar T Overton, Tricia Burdo, Jacqueline M Flynn, Michael T Lu, Jana Taron, Samuel R Schnittman, Kathleen V Fitch, Markella V Zanni, Ca...> ;Journal of Acquired Immune Deficiency Syndromes. 2024 Apr 15
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial.
Bhattacharya, R., Uddin, M., Patel, A., Niroula, A., Finneran, P., Bernardo, R., Fitch, K., Lu, M., Bloomfield, G., Malvestutto, C., Aberg, J., Fichtenbaum, C., Hornsb...> ;Blood Advances. 2024 Feb 27
1 citations
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
Michael T Lu, Heather Ribaudo, Borek Foldyna, Markella V Zanni, Thomas Mayrhofer, Julia Karady, Jana Taron, Kathleen V Fitch, Sara McCallum, Tricia H Burdo, Kayla Para...> ;JAMA Cardiology. 2024 Apr 1
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
Borek Foldyna, Thomas Mayrhofer, Markella V Zanni, Asya Lyass, Radhika Barve, Julia Karady, Sara McCallum, Tricia H Burdo, Kathleen V Fitch, Kayla Paradis, Evelynne S ...> ;Clinical Infectious Diseases. 2023 Dec 15
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus.
Samuel R Schnittman, Márton Kolossváry, Gabriele Beck-Engeser, Kathleen V Fitch, Gabrielle C Ambayec, Robin M Nance, Markella V Zanni, Marissa Diggs, Fay Chan, Sara Mc...> ;Open Forum Infectious Diseases. 2023 Oct 1
2 citations
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
Jordan E Lake, Jana Taron, Heather J Ribaudo, Jorge Leon-Cruz, Netanya S Utay, Shobha Swaminathan, Kathleen V Fitch, Emma M Kileel, Kayla Paradis, Evelynne S Fulda, Ke...> ;AIDS. 2023 Nov 15
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.
Kristine M Erlandson, Triin Umbleja, Michael T Lu, Jana Taron, Heather J Ribaudo, Edgar T Overton, Rachel M Presti, David W Haas, Paul E Sax, Michael T Yin, Bingxue Kr...> ;Journal of Acquired Immune Deficiency Syndromes. 2023 Oct 1
Research Initiative Supporting Excellence at the University of Cincinnati (RISE-UC): A Program to Develop and Support Research-Active Faculty Members.
Kevin J Haworth, Kelly C Niederhausen, Eric P Smith, Sakthivel Sadayappan, Yolanda Wess, Jack Rubinstein, Daniel P Schauer, Manoocher Soleimani, Gregory W Rouan, Carl ...> ;Academic Medicine. 2023 Oct 1
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.
Márton Kolossváry, Chris deFilippi, Sara McCallum, Kathleen V Fitch, Marissa R Diggs, Evelynne S Fulda, Heather J Ribaudo, Carl J Fichtenbaum, Judith A Aberg, Carlos D...> ;Ebiomedicine. 2023 Apr 1
3 citations
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.
Samuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, Markella V Zanni, Sara McCallum, Jessica Shih-Lu Lee, Sally Shin, Brandon J Davis, Evelynne S Fulda, Marissa R Di...> ;JCI Insight. 2023 Mar 8
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?
Carl J Fichtenbaum, Patrick Mallon> ;AIDS. 2023 Mar 1
1 citations
Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus.
Samuel R Schnittman, Douglas W Kitch, Talia H Swartz, Tricia H Burdo, Kathleen V Fitch, Sara McCallum, Jacqueline M Flynn, Evelynne S Fulda, Marissa R Diggs, Jack T St...> ;Open Forum Infectious Diseases. 2023 Mar 1
1 citations
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immu...
Emma M Kileel, Carlos D Malvestutto, Janet Lo, Kathleen V Fitch, Carl J Fichtenbaum, Judith A Aberg, Markella V Zanni, Esteban Martinez, Nwora Lance Okeke, Princy Kuma...> ;Clinical Infectious Diseases. 2023 Jun 8
Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV.
Laura Atehortua, Mirza Baig, Jamie Morris, Sarah Trentman, W Sean Davidson, Carl J Fichtenbaum, Claire A Chougnet> ;Frontiers in Immunology. 2023 Jan 1
5 citations
Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection.
Manuel G Feria, Cecilia Chang, Eduardo Ticona, Anissa Moussa, Bin Zhang, Isabel Ballena, Ruben Azañero, Cesar Ticona, Carlo N De Cecco, Carl J Fichtenbaum, Robert E O'...> ;Open Forum Infectious Diseases. 2022 Dec 1
1 citations
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.
Evelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, Markella V Zanni, Judith A Aberg, Carlos Malvestutto, Sandra Wagner Cardoso, Baiba Berzins, Rita Lira, Regina Hard...> ;Contemporary Clinical Trials. 2023 Jan 1
3 citations
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
Pamela S Douglas, Sara McCallum, Michael T Lu, Triin Umbleja, Kathleen V Fitch, Borek Foldyna, Markella V Zanni, Evelynne S Fulda, Gerald S Bloomfield, Carl J Fichtenb...> ;AIDS. 2023 Mar 1
1 citations
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk.
Kathleen V Fitch, Sara A McCallum, Kristine M Erlandson, Edgar Turner Overton, Markella V Zanni, Carl Fichtenbaum, Judith A Aberg, Evelynne S Fulda, Emma M Kileel, Lau...> ;AIDS. 2022 Nov 15
4 citations
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
Markella V Zanni, Borek Foldyna, Sara McCallum, Tricia H Burdo, Sara E Looby, Kathleen V Fitch, Evelynne S Fulda, Patrick Autissier, Gerald S Bloomfield, Carlos D Malv...> ;Clinical Infectious Diseases. 2023 Jan 13
17 citations
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.
Rachel J Hagey, Menashe Elazar, Edward A Pham, Siqi Tian, Lily Ben-Avi, Claire Bernardin-Souibgui, Matthew F Yee, Fernando R Moreira, Meirav Vilan Rabinovitch, Rita M ...> ;Nature Medicine. 2022 Sep 1
4 citations
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, Tricia H Burdo, Kathleen V Fitch, Sara McCallum, Evelynne S Fulda, Markella V Zanni, Borek Foldyna, Carlos Malvest...> ;Clinical Infectious Diseases. 2023 Feb 8
5 citations
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
Edgar T Overton, Isabelle R Weir, Markella V Zanni, Stephanie Fischinger, Rodger D MacArthur, Judith A Aberg, Kathleen V Fitch, Michael Frank, Helmut Albrecht, Elliot ...> ;Journal of Acquired Immune Deficiency Syndromes. 2022 Aug 1
4 citations
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
Márton Kolossváry, Chris deFilippi, Michael T Lu, Markella V Zanni, Evelynne S Fulda, Borek Foldyna, Heather Ribaudo, Thomas Mayrhofer, Ann C Collier, Gerald S Bloomfi...> ;The Journal of Infectious Diseases. 2022 Nov 11
3 citations
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on ...
Sara E Looby, Amy Kantor, Tricia H Burdo, Judith S Currier, Carl J Fichtenbaum, Edgar T Overton, Judith A Aberg, Carlos D Malvestutto, Gerald S Bloomfield, Kristine M ...> ;Clinical Infectious Diseases. 2022 Oct 12
3 citations
Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
Gerald S Bloomfield, Isabelle R Weir, Heather J Ribaudo, Kathleen V Fitch, Carl J Fichtenbaum, Laura E Moran, Roger Bedimo, Christopher de Filippi, Caryn G Morse, Jona...> ;Journal of Acquired Immune Deficiency Syndromes. 2022 Mar 1
Join now to see all

Journal Articles

Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...
Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Diane Havlir, Clinical Infectious Diseases

Press Mentions

Here’s How the End of the COVID-19 Public Health Emergency Could Affect You, According to MDsFebruary 14th, 2023
'It's Happening a Little Bit Earlier.' Flu Hospitalizations Rise in Southwest OhioNovember 10th, 2022
Heading into Colder Months, Health Experts Remind of Importance of COVID and Flu VaccinesOctober 3rd, 2022
Join now to see all

Grant Support

University Of Cincinnati AIDS Clinical Trials Unit- UC ActuNational Institute Of Allergy And Infectious Diseases2008–2012
HIV Protease Inhibitors And Calcium Channel BlockersNational Center For Research Resources2004
ACTG A5108 Efavirenz/Nelfinavir StudyNational Center For Research Resources2004
Epidemiology And Outcome Of STDS In Drug UsersNational Institute On Drug Abuse1999
Washu55--Orally Administered SP 303 Treatment Of Diarrhea Aids--37, 554National Center For Research Resources1999
Epidemiology And Outcome Of STDS In Drug UsersNational Institute On Drug Abuse1996–1998

Hospital Affiliations

University of Cincinnati Medical CenterCincinnati, Ohio
Cincinnati Veterans Affairs Medical CenterCincinnati, Ohio